Potential Interplay between Hyperosmolarity and Inflammation on Retinal Pigmented Epithelium in Pathogenesis of Diabetic Retinopathy.

François Willermain, Lisa Scifo, Célia Weber, Laure Caspers, Jason Perret, Christine Delporte

Journal: International journal of molecular sciences 2018;19(4):1056

PMID: 29614818

Abstract

Diabetic retinopathy is a frequent eyesight threatening complication of type 1 and type 2 diabetes. Under physiological conditions, the inner and the outer blood-retinal barriers protect the retina by regulating ion, protein, and water flux into and out of the retina. During diabetic retinopathy, many factors, including inflammation, contribute to the rupture of the inner and/or the outer blood-retinal barrier. This rupture leads the development of macular edema, a foremost cause of sight loss among diabetic patients. Under these conditions, it has been speculated that retinal pigmented epithelial cells, that constitute the outer blood-retinal barrier, may be subjected to hyperosmolar stress resulting from different mechanisms. Herein, we review the possible origins and consequences of hyperosmolar stress on retinal pigmented epithelial cells during diabetic retinopathy, with a special focus on the intimate interplay between inflammation and hyperosmolar stress, as well as the current and forthcoming new pharmacotherapies for the treatment of such condition.

Address: Department of Ophthalmology, CHU Saint-Pierre and Brugmann, 1000 Brussels, Belgium. [email protected].; Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM), Université Libre de Bruxelles, 1050 Brussels, Belgium. [email protected].; Department of Ophthalmology, CHU Saint-Pierre and Brugmann, 1000 Brussels, Belgium. [email protected].; Laboratory of Pathophysiological and Nutritional Biochemistry, Université Libre de Bruxelles, 1050 Brussels, Belgium. [email protected].; Department of Ophthalmology, CHU Saint-Pierre and Brugmann, 1000 Brussels, Belgium. [email protected].; Laboratory of Pathophysiological and Nutritional Biochemistry, Université Libre de Bruxelles, 1050 Brussels, Belgium. [email protected].; Department of Ophthalmology, CHU Saint-Pierre and Brugmann, 1000 Brussels, Belgium. [email protected].; Laboratory of Pathophysiological and Nutritional Biochemistry, Université Libre de Bruxelles, 1050 Brussels, Belgium. [email protected].; Laboratory of Pathophysiological and Nutritional Biochemistry, Université Libre de Bruxelles, 1050 Brussels, Belgium. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.